Welcome to LookChem.com Sign In|Join Free

CAS

  • or

309735-44-2

1-Piperidinecarboxylic acid, 3-[(phenylamino)methyl]-, 1,1-dimethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

309735-44-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 309735-44-2 Structure

  • Basic information

    1. Product Name: 1-Piperidinecarboxylic acid, 3-[(phenylamino)methyl]-, 1,1-dimethylethyl ester
    2. Synonyms: 3-phenylaminomethylpiperidine-1-carboxylic acid tert-butyl ester;N-(1-Boc-piperidin-3-ylmethyl)aniline;N-(1-Boc-piperidin-3-ylmethyl)-aniline;
    3. CAS NO:309735-44-2
    4. Molecular Formula: C17H26N2O2
    5. Molecular Weight: 290.406
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 309735-44-2.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 1-Piperidinecarboxylic acid, 3-[(phenylamino)methyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
    10. NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 3-[(phenylamino)methyl]-, 1,1-dimethylethyl ester(309735-44-2)
    11. EPA Substance Registry System: 1-Piperidinecarboxylic acid, 3-[(phenylamino)methyl]-, 1,1-dimethylethyl ester(309735-44-2)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 309735-44-2(Hazardous Substances Data)

309735-44-2 Usage

Type of compound

Synthetic organic compound, derivative of piperidinecarboxylic acid

Uses

Intermediate in the synthesis of pharmaceutical compounds, particularly in the production of angiotensin-converting enzyme (ACE) inhibitors, which are used in the treatment of hypertension and heart failure

Structure

1-Piperidinecarboxylic acid, 3-[(phenylamino)methyl]-, 1,1-dimethylethyl ester

Functional group

Tert-butyl ester, indicating a tert-butyl group attached to the carboxylic acid functional group

Stability

More stable and easier to handle in laboratory settings due to the presence of the tert-butyl group

Safety precautions

May be harmful if ingested or inhaled, and could be a skin and eye irritant, so it should be handled with caution.

Check Digit Verification of cas no

The CAS Registry Mumber 309735-44-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,9,7,3 and 5 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 309735-44:
(8*3)+(7*0)+(6*9)+(5*7)+(4*3)+(3*5)+(2*4)+(1*4)=152
152 % 10 = 2
So 309735-44-2 is a valid CAS Registry Number.

309735-44-2Relevant articles and documents

PIPERIDINE AMIDES AS MODULATORS OF THE GHRELIN RECEPTOR

-

Page/Page column 54-55, (2011/10/13)

Compounds of formula (I) or pharmaceutically acceptable salts thereof, are useful for the treatment of diabetes and obesity.

Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps

German, Nadezhda,Kaatz, Glenn W.,Kerns, Robert J.

, p. 1368 - 1373 (2008/12/23)

Phenylpiperidine selective serotonin reuptake inhibitors (PSSRIs) block the function of selected multidrug efflux pumps of Staphylococcus aureus. In this study PSSRI-based piperidine derivatives were prepared, evaluated for inhibition of two multidrug res

Heterocyclic analgesic compounds and methods of use thereof

-

, (2008/06/13)

One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.

Heterocyclic analgesic compounds and methods of use thereof

-

, (2008/06/13)

One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.

Antipsychotic sulfonamide-heterocycles, and methods of use thereof

-

, (2008/06/13)

One aspect of the present invention relates to heterocyclic compounds comprising a sulfonamide moiety. A second aspect of the present invention relates to the use of the heterocyclic compounds comprising a sulfonamide moiety to treat diseases, afflictions or maladies caused at least in part by abnormal activity of one or more GPCRs or ligand-gated ion channels. An additional aspect of the present invention relates to the synthesis of combinatorial libraries of the heterocyclic compounds comprising a sulfonamide moiety, and the screening of those libraries for biological activity, e.g., in animal models of psychosis.

Heterocyclic analgesic compounds and methods of use thereof

-

, (2008/06/13)

One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 309735-44-2